Breaking News From Pharma & Bio Ingredients Subscribe via RSS Subscribe via RSS



February 25, 2005



Memory Pharmaceuticals Commences Phase I Study of MEM 3454


Posted on 2005-02-25 06:07:00



Mylan FDA Nebivolol Decision Date Is Postponed by the FDA


Posted on 2005-02-25 06:07:00



February 24, 2005



Chiron Names Goldstein President, COO


Posted on 2005-02-24 06:07:00



DOV Initiates Phase I Trial for Depression


Posted on 2005-02-24 06:06:00



Genzyme Begins Phase II Trial for Peripheral Arterial Disease


Posted on 2005-02-24 06:06:00



James D. Watson Helix Awards Honor Biotech's Top Performers


Posted on 2005-02-24 06:06:00



February 23, 2005



European Commission Approves Truvada


Posted on 2005-02-23 06:05:00



Memory Launches PDE10A Inhibitor Program


Posted on 2005-02-23 06:05:00



February 11, 2005



BioProgress Earns Patent for Oral Dosage


Posted on 2005-02-11 06:04:00



Watson Pharmaceuticals Fourth-Quarter Earnings Grow 4 Percent


Posted on 2005-02-11 06:04:00



Mylan Gets Tentative Approval for Wake-Up Pill


Posted on 2005-02-11 06:03:00



February 10, 2005



Cephalon Says Nuvigil Drug Improved Wakefulness in Late-Stage Trial


Posted on 2005-02-10 06:03:00



2004 Sales Surge for Genaissance Pharmaceuticals


Posted on 2005-02-10 06:01:00



Generex Biotechnology To Develop Small Pox Vaccine


Posted on 2005-02-10 06:00:00



February 9, 2005



Clinical Trial Set for Oral Spray to Reduce Chemotherapy-Induced Nausea


Posted on 2005-02-09 15:46:00



NEWS ARCHIVES

2008

2007

2006

2005

2004

NEWSLETTER SIGNUP